GROWTH IN PHARMA SECTOR (23/01/2017)
The pharma sector is expected to grow by 20 per cent on account of relaxed foreign direct investment (FDI) norms and a separate ministry to focus on the sunrise sector is on the anvil, Chemical and Fertiliser Minister Ananth Kumar today said.
Bill to amend existing Drugs Act withdrawn (23/01/2017)
As part of the health ministry's move to replace the old laws governing India's pharmaceutical and medical devices industries, the government on Wednesday withdrew a Bill introduced in Parliament in 2013 to amend the existing Drugs and Cosmetics Act.
Government invites entries for NPPA logo (23/01/2017)
The Department of Pharmaceuticals plans to differentiate drugs under price control and make it easier for patients to identify them by printing a logo of price regulator NPPA on packages. The department is seeking designs of logo for National Pharmaceutical Pricing Authority (NPPA) through a public contest.
The rationale behind the move is that the consumers understand if a medicine has the logo then its price is fixed and therefore he or she can't be overcharged, the official added. DoP is looking for a logo of NPPA which would carry a tag 'Medicine under price control/UPC' that can be used on medicine strips, labels and on medicine bottles.
Government set to release revised biosimilar guidelines in July 2016 (23/01/2017)
The government is set to release the much awaited revised guidelines for the approval of biosimilar drugs in the first week of July, a move that would bring clarity to the launch of such drugs in the country.
At the same time, the final revised guidelines clarify parts of the draft that could have been interpreted in more ways than one, the official said.
The latest revisions come amid questions from global drug makers like Swiss biotech giant Roche, which dragged the government to court over the process followed for approvals of a few such drugs.
India beats China in pharma exports in 2015 (23/01/2017)
India's pharmaceutical fares proceeded with its lead over China in 2015, as indicated by the legislature.
India's pharma sends out grew 7.55% to $12.54 billion in 2015 contrasted with China's pharma trades, which grew 5.3% to $6.94 billion amid the same time frame, the service said in an official proclamation.
"India pushed forward of China in exceptionally imperative markets, for example, US, European Union and Africa," the service said.
India's fares of pharma items to US grew 23.4% to $4.74 billion from $3.84 billion, the service said. In the meantime, China's fares to the US amid the same time frame became just 15% to $1.34 billion from $1.16 billion, the service included.
As indicated by the service, India's pharma fares to the EU and Africa were likewise more noteworthy than China's in 2015. While India sent out $1.5 billion and $3.04 billion-worth of pharma items to the EU and African markets separately, China's e ..
"A sizeable measure of the crude material utilized as a part of pharma items sent out to Africa is transported in from China," he told.
India is likewise reliant on Chinese crude materials for pharma items sold inside the nation as a result of value control and solid rivalry between medication creators taking into account the Indian business sector, Veeramani included.
"In India, the cost has descended such a great amount of that, in rivalry, we need to purchase from China. Indian producers are not ready to beat the import cost from China.